Answers are grounded in this paper and cite their sources.
Objective: Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease, and the effects of p-cresyl sulfate (PCS) and p-cresyl glucuronide (PCG) in PBC remain unclear. This study aimed to evaluate the pro-apoptotic and pro-inflammatory effects of PCS and PCG. Methods: Human intrahepatic biliary epithelial cells (HIBEpiCs) were treated with PCS or PCG, and apoptosis was assessed by flow cytometry. Female C57BL/6 mice received intraperitoneal PCS or PCG. Liver inflammation was evaluated by H&E staining, apoptosis-related proteins (caspase-3, Bax, Bcl-2) by Western blotting, and serum TGF-β and IFN-γ by ELISA. Hepatic caspase-3 and Bax were upregulated, whereas Bcl-2 was downregulated in a time-dependent manner. Conclusions: PCS and PCG promote intrahepatic inflammation and BEC apoptosis, suggesting that gut microbial metabolites may contribute to hepatobiliary immune injury.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: